Delivery Order SPE2DB22D3016-SPE2DB25FABS7

Award Date 10/28/24
Potential Completion Date 11/19/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Herceptin 150 mg vials. The $21,937.68 firm fixed-price delivery order has an ultimate completion date of January 2, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Herceptin 150 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $8,835.30 and a performance period through April 24, 2024. Amerisourcebergen Drug...
This federal contract award, valued at $5,301.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,912,337 units of the pharmaceutical product Herceptin (150 mg vials) with a completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award, valued at $2,670.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HERCEPTIN 150 MG VIALS, a medical product, with a performance period through June 17, 2025. The contract has a firm fixed-price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This contract award to AmerisourceBergen Drug Corp is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC). The $17,670.60 firm fixed-price contract is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical used to treat certain types of breast cancer. The contract has an ultimate completion date of January 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 IDC with the...
The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,068.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide HERCEPTIN 150 MG VIALS. The delivery order is part of Amerisourcebergen Drug Corp's larger, single-award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $26,704.20 firm-fixed-price contract is for the delivery of HERCEPTIN 150 MG VIALS, a medical supply. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,392.44. The contract is for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FABS7
    Delivery Order

This federal contract award is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,650.59 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, on October 28, 2022, with a completion date of November 19, 2024. The contract is not designated as a set-aside award.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/2/25, 12:07 AM